NRCT-202XR

· Neurocentria, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NRCT-202XR, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder [Phase 2]

See pricing